BioSupply Trends Quarterly logo
Subscribe
Winter 2011 - Plasma
  Download Issue
Share

Up Front

Publisher's Corner
Precious Proteins
By Patrick M. Schmidt

Features

BioSupply Trends Quarterly Winter 2011 Plasma Therapies

Plasma Therapies: Where Are We Now?

The Role of Hyperimmune Globulins

The Highs and Lows of Managing and Treating Diabetes

Specialty Drugs on the Rise

BioTrends Watch

Washington Report
Hospital Outpatient Reimbursement Increased for 2011
Massachusetts Moves Forward to Implement ACOs
An Update on Specialty Drug Tiers
Reimbursement FAQs
Reimbursement FAQs: IVIG vs SCIG, Medicare Benefits and More
Industry News
Pay-for-Performance Effective Incentive
CDC Revises Flu Death Estimate
FDA OKs Prolastin-C for AAT Deficiency
Serum Albumin Levels Linked to Multiple Myeloma Severity
Vaccine Update
People and Places in the News - January 2011
Myths and Facts: Measles and Mumps
Kaiser Foundation Launches Health Reform Source Site
Vaccine May Fight Cancer and HIV
Benlysta Benefits Lupus Patients in Drug Trial
Treatment Under Development for Autoimmune Diseases
Teva Launches Lupus Clinical Trial
Vaccines Court Rejects Mercury-Autism Link
Company to Provide In-Home Clinical Trials
Genetic Link Found Between Parkinson’s and Immune System
Gene Therapy Tested for Hemophilia B
Vaccine Sales Growing

BioFocus

Industry Insight
The Mysterious Tale of von Willebrand Disease
By Keith Berman, MPH, MBA
Patient Profile
A New Kind of Normal
By Trudie Mitschang

BioSources

BioResearch
A Higher IgG Trough Level May Reduce Risk of Pneumonia in PIDD Patients on IVIG Therapy
Intradermal Flu Vaccine at Reduced Dose Elicits Similar Response as Full-Dose IM Injection in Older Adults
In Vitro IVIG Anti-Complement Activity Points to Potential Mechanism of Action in MMN